Back to Search
Start Over
Anti-Tau Antibody Semorinemab Fails to Slow Alzheimer Disease.
- Source :
-
JAMA [JAMA] 2022 Aug 02; Vol. 328 (5), pp. 415. - Publication Year :
- 2022
- Subjects :
- Brain drug effects
Brain immunology
Humans
Alzheimer Disease drug therapy
Alzheimer Disease immunology
Antibodies, Monoclonal immunology
Antibodies, Monoclonal therapeutic use
Neuroprotective Agents immunology
Neuroprotective Agents therapeutic use
tau Proteins antagonists & inhibitors
tau Proteins immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1538-3598
- Volume :
- 328
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- JAMA
- Publication Type :
- Academic Journal
- Accession number :
- 35916858
- Full Text :
- https://doi.org/10.1001/jama.2022.12727